Acorda Therapeutics, Inc. Operating Lease Cost
Acorda Therapeutics, Inc. reported Operating Lease Cost of $214.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-05-14
- Acorda Therapeutics, Inc. operating lease, cost for the quarter ending 2024-03-31 was $214.00K, a 52.44% decline year-over-year.
- Acorda Therapeutics, Inc. operating lease, cost for the quarter ending 2023-12-31 was $204.00K, a 54.97% decline year-over-year.
- Acorda Therapeutics, Inc. operating lease, cost for the quarter ending 2023-09-30 was $448.00K, a 3.94% increase year-over-year.
- Acorda Therapeutics, Inc. operating lease, cost for the quarter ending 2023-06-30 was $444.00K, a 70.04% decline year-over-year.
- Acorda Therapeutics, Inc. operating lease, cost for fiscal 2023 was $1.55M, a 59.77% decline from fiscal 2022.
- Acorda Therapeutics, Inc. operating lease, cost for fiscal 2022 was $3.84M, a 36.27% decline from fiscal 2021.
- Acorda Therapeutics, Inc. operating lease, cost for fiscal 2021 was $6.03M, a 14.66% decline from fiscal 2020.
- Acorda Therapeutics, Inc. operating lease, cost for fiscal 2020 was $7.07M, a 0.06% decline from fiscal 2019.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-03-31 | $214.00K 10-Q · filed 2024-05-14 | $418.00K derived: sum of 2 quarters · filed 2024-05-14 | $866.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.31M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $652.00K derived: sum of 2 quarters · filed 2024-04-01 | $1.10M derived: sum of 3 quarters · filed 2024-04-01 | $1.55M 10-K · filed 2024-04-01 |
| 2023-09-30 | $448.00K 10-Q · filed 2023-11-14 | $892.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.34M 10-Q · filed 2023-11-14 | $1.79M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-06-30 | $444.00K 10-Q · filed 2023-08-09 | $894.00K 10-Q · filed 2023-08-09 | $1.35M derived: sum of 3 quarters · filed 2024-05-14 | $1.78M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-03-31 | $450.00K 10-Q · filed 2024-05-14 | $903.00K derived: sum of 2 quarters · filed 2024-05-14 | $1.33M derived: sum of 3 quarters · filed 2024-05-14 | $2.82M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $453.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $884.00K derived: sum of 2 quarters · filed 2024-04-01 | $2.37M derived: sum of 3 quarters · filed 2024-04-01 | $3.84M 10-K · filed 2024-04-01 |
| 2022-09-30 | $431.00K 10-Q · filed 2023-11-14 | $1.91M derived: sum of 2 quarters · filed 2023-11-14 | $3.39M 10-Q · filed 2023-11-14 | $4.83M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.48M 10-Q · filed 2023-08-09 | $2.96M 10-Q · filed 2023-08-09 | $4.40M derived: sum of 3 quarters · filed 2023-08-09 | $6.00M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $1.48M 10-Q · filed 2023-05-11 | $2.92M derived: sum of 2 quarters · filed 2023-05-11 | $4.51M derived: sum of 3 quarters · filed 2023-05-11 | $5.92M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $3.04M derived: sum of 2 quarters · filed 2023-03-15 | $4.45M derived: sum of 3 quarters · filed 2023-03-15 | $6.03M 10-K · filed 2023-03-15 |
| 2021-09-30 | $1.60M 10-Q · filed 2022-11-14 | $3.01M derived: sum of 2 quarters · filed 2022-11-14 | $4.59M 10-Q · filed 2022-11-14 | $6.09M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.41M 10-Q · filed 2022-08-09 | $2.99M 10-Q · filed 2022-08-09 | $4.49M derived: sum of 3 quarters · filed 2022-08-09 | $6.26M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.59M 10-Q · filed 2022-05-13 | $3.08M derived: sum of 2 quarters · filed 2022-05-13 | $4.86M derived: sum of 3 quarters · filed 2022-05-13 | $6.75M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $3.27M derived: sum of 2 quarters · filed 2022-03-18 | $5.16M derived: sum of 3 quarters · filed 2022-03-18 | $7.07M 10-K · filed 2022-03-18 |
| 2020-09-30 | $1.77M 10-Q · filed 2021-11-12 | $3.67M derived: sum of 2 quarters · filed 2021-11-12 | $5.57M 10-Q · filed 2021-11-12 | $7.35M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $1.90M 10-Q · filed 2021-08-12 | $3.80M 10-Q · filed 2021-08-12 | $5.57M derived: sum of 3 quarters · filed 2021-08-12 | $7.35M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $1.90M 10-Q · filed 2021-05-12 | $3.68M derived: sum of 2 quarters · filed 2021-05-12 | $5.45M derived: sum of 3 quarters · filed 2021-05-12 | $7.19M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $3.55M derived: sum of 2 quarters · filed 2021-03-16 | $5.29M derived: sum of 3 quarters · filed 2021-03-16 | $7.07M 10-K · filed 2021-03-16 |
| 2019-09-30 | $1.78M 10-Q · filed 2020-11-06 | $3.51M derived: sum of 2 quarters · filed 2020-11-06 | $5.29M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $1.74M 10-Q · filed 2020-08-07 | $3.52M 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $1.78M 10-Q · filed 2020-05-08 |